SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-13-002870
Filing Date
2013-05-15
Accepted
2013-05-15 16:15:33
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2103 tnib_10q.htm 10-Q 813524
2 CEO CERTIFICATION tnib_ex311.htm EX-31.1 14145
3 CFO CERTIFICATION tnib_ex312.htm EX-31.2 14060
4 CEO CERTIFICATION tnib_ex321.htm EX-32.1 7034
5 CFO CERTIFICATION tnib_ex322.htm EX-32.2 6997
  Complete submission text file 0001354488-13-002870.txt   2705237

Data Files

Seq Description Document Type Size
6 tnib-20130331.xml EX-101.INS 277783
7 tnib-20130331.xsd EX-101.SCH 28829
8 tnib-20130331_cal.xml EX-101.CAL 31992
9 tnib-20130331_def.xml EX-101.DEF 28907
10 tnib-20130331_lab.xml EX-101.LAB 138424
11 tnib-20130331_pre.xml EX-101.PRE 97185
Mailing Address 477 SOUTH ROSEMARY AVENUE, SUITE 315 WEST PALM BEACH FL 33401
Business Address 477 SOUTH ROSEMARY AVENUE, SUITE 315 WEST PALM BEACH FL 33401 407-680-3097
TNI BIOTECH, INC. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 13847265
SIC: 2834 Pharmaceutical Preparations